Skip to main content
H

Hunan Hansen Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 002412 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,320 across all filing types
Latest filing 2025-10-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002412

About Hunan Hansen Pharmaceutical Co.,Ltd.

https://www.hansenzy.com

Hunan Hansen Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio encompasses a diverse range of chemical drugs and traditional Chinese medicine (TCM) preparations. Key therapeutic areas include cardiovascular health, digestive system disorders, and anti-infective treatments. Notable products include Simotang Oral Liquid, a widely recognized TCM for gastrointestinal motility, and various chemical formulations such as Simvastatin tablets. The company operates modern production facilities compliant with Good Manufacturing Practice (GMP) standards and maintains a robust R&D infrastructure focused on drug innovation and formulation optimization. Its operations integrate traditional medicinal knowledge with contemporary pharmacological technology to serve healthcare markets through a comprehensive supply chain and clinical research initiatives.

Recent filings

Filing Released Lang Actions
提名委员会议事规则(2025年10月)
Regulatory Filings
2025-10-27 Chinese
董事及高级管理人员所持本公司股份及其变动管理办法(2025年10月)
Regulatory Filings
2025-10-27 Chinese
审计委员会议事规则(2025年10月)
Regulatory Filings
2025-10-27 Chinese
防范大股东及关联方资金占用专项制度(2025年10月)
Regulatory Filings
2025-10-27 Chinese
内幕交易防控工作业绩考评办法(2025年10月)
Regulatory Filings
2025-10-27 Chinese
会计师事务所选聘制度(2025年10月)
Regulatory Filings
2025-10-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.